REVIVA PHARMACEUTICALS HOLDINGS, INC.

RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

RVPH

Insider Sentiment (TTM):

Last Purchase:2022-11-18Last Sale:2020-12-08Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:3,367,852Shares Outstanding:7,022,945Institutional Ownership Pct.:47.95%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash And Cash Equivalents At Carrying Value	20	22	14	13	10	5	13	6	6	12	23	5
Assets Current	21	24	15	14	11	6	15	7	7	-	24	-
Prepaid Expense And Other Assets Current	0	1	1	0	0	1	1	0	1	1	0	0
Prepaid Expense Noncurrent	-	-	-	-	-	-	-	-	1	-	-	-
Assets	21	24	16	14	12	7	16	8	8	13	24	5
Short Term Borrowings	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Payable Current	2	2	3	5	5	5	6	9	5	6	4	5
Liabilities Current	6	6	7	10	12	12	15	18	14	14	17	13
Employee Related Liabilities Current	0	0	0	1	1	1	1	1	1	1	1	-
Liabilities
Liabilities	6	6	7	10	12	12	15	18	14	15	18	14
Other Accrued Liabilities Current	0	1	1	1	1	0	1	0	0	0	0	-
Derivative Liabilities Noncurrent	-	-	0	0	0	0	0	0	0	0	1	1
Liabilities And Stockholders Equity	21	24	16	14	12	7	16	8	8	13	24	5
Additional Paid In Capital	205	205	193	185	176	166	165	148	144	140	140	112
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	-
Stockholders Equity
Stockholders Equity	15	17	9	5	-0	-4	1	-10	-6	-1	6	-13
Retained Earnings Accumulated Deficit	-190	-187	-184	-181	-177	-171	-164	-158	-150	-142	-134	-121
Equity
Stockholders Equity Note
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	515	515	315	315	315	315	315	115	115	115	315	115
Shares Outstanding	13	13	6	5	3	2	2	2	1	1	1	1
Common Stock Shares Issued	13	13	6	5	3	2	2	2	1	1	1	1
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	103.07%	87.45%	24.35%	-	-	-	-	-	-	-	-	-
2025	-2.09%	-57.09%	-48.08%	-5.83%	16.90%	28.64%	13.86%	-42.71%	-45.96%	36.42%	-37.42%	-7.58%
2024	-21.10%	-35.89%	-44.66%	88.00%	74.07%	36.12%	36.36%	57.02%	56.20%	51.77%	82.79%	24.54%
2023	-	-	-	8.87%	22.78%	16.55%	-26.89%	-5.38%	-30.54%	-46.26%	-58.62%	-66.38%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.56	3.85	2.08	1.39	0.90	0.54	1.01	0.39	0.52	-	1.38	-
Quick Ratio	3.50	3.76	1.98	1.36	0.87	0.48	0.96	0.37	0.48	-	1.37	-
Working Capital	15.21M	17.44M	7.83M	3.77M	-1.26M	-5.25M	81.86K	-10.72M	-6.71M	-	6.53M	-
Leverage & Debt
Debt to Equity	0.39	0.35	0.84	2.15	-26.34	-2.59	18.08	-1.76	-2.33	-11.03	3.14	-1.09
Interest Coverage TTM	-756.66	-860.68	-819.74	-965.98	-1,041.27	-1,104.58	-1,665.07	-1,183.10	-1,257.69	-1,086.77	-954.66	-1,580.10
Debt Ratio	0.28	0.26	0.46	0.68	1.04	1.63	0.95	2.31	1.75	-	0.76	-
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	-
Per Share Metrics
Free Cash Flow Per Share TTM	-1.64	-2.88	-6.78	-5.42	-7.28	-12.19	-19.88	-19.71	-23.08	-21.48	-23.80	-20.42
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-51.97%	-42.50%	-33.60%	-31.07%	-24.68%	-27.42%	-23.79%	-21.29%	5.51%	43.59%	38.92%	110.72%
EPS Growth (1Y)	-90.83%	-79.84%	-69.11%	-67.94%	-54.39%	-55.96%	-46.27%	-44.97%	-22.53%	4.89%	13.93%	71.79%
Valuation Metrics
P/E TTM	-0.64	-0.31	-1.02	-1.18	-0.71	-1.62	-2.04	-1.47	-1.09	-2.84	-3.12	-2.75
P/B TTM	0.55	0.29	2.34	5.89	-41.88	-10.53	75.19	-4.88	-6.47	-83.94	21.43	-9.00
Market Cap	8.31M	5.12M	20.24M	26.79M	19.23M	46.98M	61.10M	48.68M	39.11M	112.97M	122.56M	115.35M
Enterprise Value	-11.44M	-16.83M	6.21M	13.61M	8.98M	41.91M	48.08M	43.20M	33.14M	101.33M	99.19M	110.60M
Calculated Values
Free Cash Flow TTM	-21.70M	-20.20M	-24.59M	-19.70M	-18.35M	-30.01M	-33.54M	-33.32M	-35.26M	-32.10M	-28.32M	-24.14M
Net Debt	-19.75M	-21.96M	-14.03M	-13.18M	-10.25M	-5.07M	-13.02M	-5.48M	-5.97M	-11.64M	-23.37M	-4.75M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2022-11-18Purchase

Owner: Patel, Purav

Title: -

Shares: 3,000

Price/Share: $4.69

Value: $14,070.00

Shares Owned: 43,547

Relationship: Director

Ownership: Direct

2022-09-30Purchase

Owner: Narayan, Prabhu

Title: Chief Financial Officer

Shares: 50,000

Price/Share: $1.66

Value: $83,000.00

Shares Owned: 100,000

Relationship: Officer

Ownership: Direct

2022-06-30Purchase

Owner: Narayan, Prabhu

Title: Chief Financial Officer

Shares: 50,000

Price/Share: $1.21

Value: $60,500.00

Shares Owned: 50,000

Relationship: Officer

Ownership: Direct

2021-06-01Purchase

Owner: Vedanta, Associates-R, Lp…

Title: -

Shares: 1,330,000

Price/Share: $3.75

Value: $4,987,500.00

Shares Owned: 931,000

Relationship: Director,TenPercentOwner

Ownership: Indirect

2020-12-08Sale

Owner: Glazer, Capital, Llc, Gla…

Title: -

Shares: 367,000

Price/Share: $10.88

Value: $3,992,960.00

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2022-11-18	Patel, Purav	Director	-	Direct	Purchase	3,000	4.69	$14,070.00	43,547	4
2022-09-30	Narayan, Prabhu	Officer	Chief Financial Officer	Direct	Purchase	50,000	1.66	$83,000.00	100,000	4
2022-06-30	Narayan, Prabhu	Officer	Chief Financial Officer	Direct	Purchase	50,000	1.21	$60,500.00	50,000	4
2021-06-01	Vedanta, Associates-R, Lp…	Director,TenPercentOwner	-	Indirect	Purchase	1,330,000	3.75	$4,987,500.00	931,000	4
2020-12-08	Glazer, Capital, Llc, Gla…	TenPercentOwner	-	Indirect	Sale	367,000	10.88	$3,992,960.00	0	4
2020-12-07	Gerber, Sander, Hudson Ba…	TenPercentOwner	-	Indirect	Sale	50,000	11.51	$575,500.00	710,000	4
2020-12-02	Glazer, Paul J, Glazer Ca…	TenPercentOwner	-	Indirect	Sale	261	11.00	$2,871.00	606,360	4
2020-12-01	Glazer, Capital, Llc, Gla…	TenPercentOwner	-	Indirect	Sale	5,362	11.00	$58,982.00	606,621	4
2020-11-24	Glazer, Paul J, Glazer Ca…	TenPercentOwner	-	Indirect	Sale	7,103	10.90	$77,422.70	617,952	4
2020-11-18	Glazer, Paul J, Glazer Ca…	TenPercentOwner	-	Indirect	Sale	896	10.90	$9,766.40	648,666	4
2020-11-11	Glazer, Capital, Llc, Gla…	TenPercentOwner	-	Indirect	Sale	5	10.90	$54.50	649,994	4
2020-11-06	Glazer, Paul J, Glazer Ca…	TenPercentOwner	-	Indirect	Sale	1	10.90	$10.90	649,999	4
2020-11-03	Glazer, Paul J, Glazer Ca…	TenPercentOwner	-	Indirect	Sale	57,616	10.85	$625,133.60	650,000	4
2020-11-02	Gerber, Sander, Hudson Ba…	TenPercentOwner	-	Indirect	Sale	50,000	10.87	$543,500.00	760,000	4
2020-09-29	Glazer, Paul J, Glazer Ca…	TenPercentOwner	-	Indirect	Sale	2	11.50	$23.00	707,617	4
2020-09-17	Glazer, Paul J, Glazer Ca…	TenPercentOwner	-	Indirect	Sale	1,000	10.80	$10,800.00	707,619	4
2020-09-14	Glazer, Paul J, Glazer Ca…	TenPercentOwner	-	Indirect	Sale	1	10.80	$10.80	708,619	4
2020-05-08	Mizuho, Securities Usa Ll…	TenPercentOwner	-	Direct	Sale	51,000	10.62	$541,620.00	766,750	4
2020-03-20	Gerber, Sander, Hudson Ba…	TenPercentOwner	-	Indirect	Purchase	10,000	10.37	$103,700.00	810,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

47.95%

Inst. Shares: 3,367,852

Shares Outstanding: 7,022,945

2025-12-31

Inst. Shares: 11,074,235

Shares Outstanding: 3,627,890

2025-09-30

12.55%

Inst. Shares: 9,120,145

Shares Outstanding: 72,685,740

2025-06-30

27.88%

Inst. Shares: 13,896,871

Shares Outstanding: 49,847,872

2025-03-31

290.73%

Inst. Shares: 7,159,466

Shares Outstanding: 2,462,573

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	3,367,852	7,022,945	47.95%
2025-12-31	11,074,235	3,627,890	-
2025-09-30	9,120,145	72,685,740	12.55%
2025-06-30	13,896,871	49,847,872	27.88%
2025-03-31	7,159,466	2,462,573	290.73%
2024-12-31	7,674,940	1,687,738	-
2024-06-30	6,552,246	30,555,012	21.44%
2024-03-31	5,253,404	29,887,325	17.58%
2023-12-31	4,935,402	23,798,203	20.74%
2023-06-30	2,364,978	22,434,781	10.54%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) — SEC Financial Statements & Analysis

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) is a pharmaceutical preparations company, incorporated in DE. REVIVA PHARMACEUTICALS HOLDINGS, INC. trades on OTC as: RVPH. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), REVIVA PHARMACEUTICALS HOLDINGS, INC. reported a Debt-to-Equity ratio of 0.39x, a Price-to-Book (P/B) ratio of 0.55x (TTM), at a market cap of $8.31M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.39x
P/B TTM: 0.55x
Market Cap: $8.31M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is REVIVA PHARMACEUTICALS HOLDINGS, INC. in?

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) operates in the Pharmaceutical Preparations industry.

What is RVPH's market cap?

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) has a market capitalization of $8.31M as of 2026-06-30.

What exchange does RVPH trade on?

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) trades on the OTC.

Where is REVIVA PHARMACEUTICALS HOLDINGS, INC. incorporated?

REVIVA PHARMACEUTICALS HOLDINGS, INC. is incorporated in DE.